DNASENSE ApS: Financial statements 2018
CVR: 36036869
Source: annual report 2018, Danish Business Authority
01/10/2017 – 30/09/2018
DNASENSE ApS (CVR 36036869) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 2,296,217 and a net result of DKK 524,124 compared with DKK 673,206 the year before. That is an increase of 27.8% compared with the year before. Equity in the 2018 report amounted to DKK 910,026. The solvency ratio was 57%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,296,217
- Profit/Loss
- DKK 524,124
- Equity
- DKK 910,026
- Total Assets
- DKK 1,597,183
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 2.3 mio. | 524 t. | 910 t. | 2 |
| 2017 | - | 1.8 mio. | 673 t. | 886 t. | 1 |
| 2016 | - | 1.1 mio. | 359 t. | 513 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout DNASENSE ApS
DNASENSE ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Mads Toft Søndergaard. The board consists of Anders Christian Neto de Sousa Grøn (chair), Anders Mohr Christensen, Henrik Bjørn Nielsen and Manoj Nirmal Dadlani. The company is owned by Clinical-Microbiomics A/S. The company has 15 employees (2018). In 2025, the company reported a gross profit of DKK 7,915,337 and a net result of DKK 894,729. Equity in the 2025 report amounted to DKK 1,639,012.